Day: December 11, 2025

Pharmaceutical Firm Introduces Dual-Action Therapy for Metabolic Conditions

Cipla Limited has unveiled a new medication, known as Yurpeak, which contains the active pharmaceutical ingredient tirzepatide. This injectable treatment…

Read More »

European Pharma Giants Sanofi and GSK Enter Preclinical Collaboration Deals

Rival European pharmaceutical companies Sanofi and GSK have both forged new partnership agreements aimed at strengthening their respective preclinical research…

Read More »

Novartis Reports Positive Phase III Trial Data for Ianalumab in Immune Thrombocytopenia

Novartis has announced favorable outcomes from the Phase III clinical trial VAYHIT2, which assessed the efficacy of ianalumab combined with…

Read More »

Paradigm Health Acquires Flatiron Clinical Research Arm, Raises $78M to Broaden Trial Access

Paradigm Health has completed the acquisition of Flatiron Health’s clinical research business shortly after successfully raising $78 million in a…

Read More »

Eli Lilly Commits $6 Billion Investment for Major Pharmaceutical Manufacturing Hub in Alabama

The American pharmaceutical giant, Eli Lilly, has designated Huntsville, Alabama, as the location for its third manufacturing facility dedicated to…

Read More »

Urgent Nationwide Recall Issued for Specific Pain Medication Batch

The Drug Administration of Vietnam (under the Ministry of Health) has issued a decision mandating a nationwide recall for a…

Read More »

Enhancing Central Vietnam’s Medical Capacity Through International Cooperation Project

On December 10, a medical training institution in the Central region officially inaugurated a building constructed with a preferential loan…

Read More »